Verified employee & interview reviews

Novo Nordisk India Reviews

Bengaluru, Karnataka

4.7/ 5

3 reviews

Novo Nordisk India Private Limited is a leading multinational healthcare company specializing in diabetes care and other serious chronic conditions, including obesity, hemophilia, and growth disorders. Incorporated on February 7, 1994, as an unlisted private limited company, it operates as the Indian subsidiary of the Danish pharmaceutical giant Novo Nordisk A/S, which has provided insulin to India since 1935. Headquartered in Bengaluru, Karnataka, Novo Nordisk India has its registered office at Embassy Manyata Business Park. The company is a key player in the Indian pharmaceutical landscape, recognized as one of the fastest-growing multinational pharmaceutical companies in the country. Its comprehensive product portfolio features innovative medications and delivery systems, including insulin pens, GLP-1 receptor agonists, and hormone therapies. Financed with an authorized share capital of INR 33.00 crore and a paid-up capital of INR 26.50 crore, Novo Nordisk India generated an operating revenue range exceeding INR 1,000 crore, with estimations between INR 2,750 and 3,000 crore for the financial year ending March 31, 2024. Operationally, the company employs over 1,600 professionals. Beyond commercial operations, the India arm hosts local Global Business Services (GBS) and corporate functions that support global operations across the entire pharmaceutical value chain. This extensive GBS hub provides end-to-end services such as clinical data management, pharmacovigilance, regulatory affairs, quality assurance, supply chain planning, and digital innovation. The GBS unit has achieved high acclaim, being certified as the No. 1 Best Place to Work in India (GBS) and the Best Place to Work for Women by international programs. Novo Nordisk India actively collaborates with external stakeholders to advance healthcare ecosystems. Notable initiatives include partnering with IIM Ahmedabad to strengthen obesity care and working with startups like Healthify to launch AI-enabled patient support programs. Under leadership that includes Managing Director Vikrant Shrotriya, the company continues to focus on driving long-term health outcomes, expanding digital health initiatives, and ensuring an uninterrupted supply of life-saving therapies to millions of patients across India.